{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:49:55Z","timestamp":1765295395765,"version":"build-2065373602"},"reference-count":26,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T00:00:00Z","timestamp":1686873600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Natural Science Foundation of Guangdong Province","award":["2021A1515010969","20211046"],"award-info":[{"award-number":["2021A1515010969","20211046"]}]},{"DOI":"10.13039\/501100010883","name":"Research Project of Traditional Chinese Medicine Bureau of Guangdong Province","doi-asserted-by":"publisher","award":["2021A1515010969","20211046"],"award-info":[{"award-number":["2021A1515010969","20211046"]}],"id":[{"id":"10.13039\/501100010883","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Biotinidase (BTD) deficiency (OMIM 253260) is an autosomal recessively inherited metabolic disorder resulting from deficient activity of the BTD enzyme, which can cleave and release biotin from a variety of biotin-dependent carboxylases, and is therefore recognized as a tool to recycle biotin. Being a condition caused by variations on BTD gene with a consequence of free biotin shortage, BTD deficiency may impair the activity of biotin-dependent carboxylases, and thus bring about a buildup of potentially toxic compounds in the body, primarily 3-hydroxyisovaleryl-carnitine in plasma as well as 3-hydroxyisovaleric acid in urine. The phenotype of BTD deficiency may vary dramatically, from asymptomatic adults to severe neurological anomalies, even death in infancy. In the present study, we reported on a 5-month-old boy, whose parents sought for medical consultation in our clinic for their son due to his loss of consciousness, repeated tetany, and motor retardation. Detailed clinical features included severe psychomotor retardation, hypotonia, as well as failure to thrive. The brain MRI at 12 months showed cerebellar hypoplasia and multiple foci of leukodystrophy. The result of antiepileptic therapy was not satisfying. During hospitalization, BTD deficiency was suggested by elevated concentration of 3-hydroxyisovaleryl-carnitine in the blood spots and 3-hydroxyisovaleric acid in the urine. The child was then diagnosed with profound BTD deficiency based on the above findings and low BTD enzyme activity. Subsequent mutational analysis revealed a novel homozygous variant, c.637_637delC (p.H213Tfs*51) in exon 4 of BTD gene in the proband, which was recognized as a further support to the diagnosis. Therefore, biotin treatment was started immediately, eventually with satisfactory outcomes achieved in terms of prevention of epileptic seizure, performance in deep tendon reflexes, and improvement of muscular hypotonia, but unfortunately, the therapy failed to show any evident effects on poor feeding and intellectual disability. This painful lesson suggests that newborn screening for inherited metabolic diseases is essential for early identification and treatment, which should have been performed in this case to avoid this tragedy.<\/jats:p>","DOI":"10.3390\/ijms241210239","type":"journal-article","created":{"date-parts":[[2023,6,16]],"date-time":"2023-06-16T08:56:01Z","timestamp":1686905761000},"page":"10239","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Delayed Biotin Therapy in a Child with Atypical Profound Biotinidase Deficiency: Late Arrival of the Truth and a Lesson Worth Thinking"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6281-4531","authenticated-orcid":false,"given":"Shu","family":"Liu","sequence":"first","affiliation":[{"name":"Pediatric Endocrinology and Inherited Metabolic Department, Guangdong Women and Children Hospital, Guangzhou 511442, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Zhang","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology and Inherited Metabolic Department, Guangdong Women and Children Hospital, Guangzhou 511442, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi","family":"Deng","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology and Inherited Metabolic Department, Guangdong Women and Children Hospital, Guangzhou 511442, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"He","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology and Inherited Metabolic Department, Guangdong Women and Children Hospital, Guangzhou 511442, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianhua","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Guangdong Women and Children Hospital, Guangzhou 511442, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingshan","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Radiology, Guangdong Women and Children Hospital, Guangzhou 511442, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianqiong","family":"Luo","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology and Inherited Metabolic Department, Guangdong Women and Children Hospital, Guangzhou 511442, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,16]]},"reference":[{"key":"ref_1","unstructured":"Adam, M.P., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Gripp, K.W., and Amemiya, A. (1993\u20132023). GeneReviews\u00ae, University of Washington. 24 March 2000 [updated 25 May 2023]."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/BF01800475","article-title":"Worldwide survey of neonatal screening for biotinidase deficiency","volume":"14","author":"Wolf","year":"1991","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1542\/peds.79.3.482","article-title":"Sudden death associated with biotinidase deficiency","volume":"79","author":"Burton","year":"1987","journal-title":"Pediatrics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ymgme.2015.01.003","article-title":"Why screen newborns for profound and partial biotinidase deficiency?","volume":"114","author":"Wolf","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/gim.2011.6","article-title":"Biotinidase deficiency: \u201cIf you have to have an inherited metabolic disease, this is the one to have\u201d","volume":"14","author":"Wolf","year":"2012","journal-title":"Genet. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ymgme.2015.08.010","article-title":"Biotinidase deficiency: Spectrum of molecular, enzymatic and clinical information from newborn screening Ontario, Canada (2007\u20132014)","volume":"116","author":"Gannavarapu","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/humu.9329","article-title":"Biotinidase deficiency: Novel mutations and their biochemical and clinical correlates","volume":"25","author":"Wolf","year":"2005","journal-title":"Hum. Mutat."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/jimd.12073","article-title":"Biotin in metabolism, gene expression, and human disease","volume":"42","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_10","unstructured":"Bistas, K.G., and Tadi, P. (2023). StatPearls, StatPearls Publishing."},{"key":"ref_11","unstructured":"Scriver, C.R., Beaudet, A.L., Sly, W.S., and Valle, D. (2001). The Metabolic and Molecular Bases of Inherited Disease, McGraw Hill. [8th ed.]."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/gim.2017.84","article-title":"Laboratory diagnosis of biotinidase deficiency, 2017 update: A technical standard and guideline of the American College of Medical Genetics and Genomics","volume":"19","author":"Strovel","year":"2017","journal-title":"Genet. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2011.06.001","article-title":"The neurology of biotinidase deficiency","volume":"104","author":"Wolf","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13023-018-0992-2","article-title":"Genotypic and phenotypic correlations of biotinidase deficiency in the Chinese population","volume":"7","author":"Hsu","year":"2019","journal-title":"Orphanet. J. Rare Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1177\/0883073808318062","article-title":"Profound biotinidase deficiency in a child with predominantly spinal cord disease","volume":"23","author":"Chedrawi","year":"2008","journal-title":"J. Child Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pediatrneurol.2011.06.010","article-title":"Biotinidase deficiency presenting as recurrent myelopathy in a 7-year-old boy and a review of the literature","volume":"45","author":"Raha","year":"2011","journal-title":"Pediatr. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1067\/mpd.2002.121938","article-title":"Hearing loss is a common feature of symptomatic children with profound biotinidase deficiency","volume":"140","author":"Wolf","year":"2002","journal-title":"J. Pediatr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jamaophthalmol.2013.6249","article-title":"Optic neuropathy due to biotinidase deficiency in a 19-year-old man","volume":"132","author":"Haines","year":"2014","journal-title":"JAMA Ophthalmol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.braindev.2020.07.007","article-title":"Biotinidase deficiency presenting as Neuromyelitis Optica Spectrum Disorder","volume":"42","author":"Shah","year":"2020","journal-title":"Brain Dev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s11011-017-9984-5","article-title":"A treatable cause of myelopathy and vision loss mimicking neuromyelitis optica spectrum disorder: Late-onset biotinidase deficiency","volume":"32","author":"Yilmaz","year":"2017","journal-title":"Metab. Brain Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/adc.67.1.115","article-title":"A biotinidase Km variant causing late onset bilateral optic neuropathy","volume":"67","author":"Ramaekers","year":"1992","journal-title":"Arch. Dis. Child"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.gene.2015.10.010","article-title":"Biotinidase deficiency and our champagne legacy","volume":"10","author":"Wolf","year":"2016","journal-title":"Gene"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s11011-015-9690-0","article-title":"Novel imaging findings in two cases of biotinidase deficiency-a treatable metabolic disorder","volume":"30","author":"Bhat","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"E128","DOI":"10.3174\/ajnr.A1703","article-title":"Brain diffusion-weighted and diffusion tensor imaging findings in an infant with biotinidase deficiency","volume":"30","author":"Rocha","year":"2009","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/gim.2014.104","article-title":"Outcomes of individuals with profound and partial biotinidase deficiency ascertained by newborn screening in Michigan over 25 years","volume":"17","author":"Jay","year":"2015","journal-title":"Genet. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"661416","DOI":"10.3389\/fped.2021.661416","article-title":"Newborn Screening for Biotinidase Deficiency. The Experience of a Regional Center in Italy","volume":"9","author":"Maguolo","year":"2021","journal-title":"Front. Pediatr."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/12\/10239\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:56:36Z","timestamp":1760126196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/12\/10239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,16]]},"references-count":26,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["ijms241210239"],"URL":"https:\/\/doi.org\/10.3390\/ijms241210239","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2023,6,16]]}}}